Annovis Bio Inc (ANVS)
6.02
-0.01
(-0.17%)
USD |
NYSE |
May 10, 16:00
6.02
0.00 (0.00%)
After-Hours: 20:00
Annovis Bio Shareholders Equity (Quarterly): -7.751M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.751M |
| September 30, 2023 | 6.658M |
| June 30, 2023 | 20.74M |
| March 31, 2023 | 20.14M |
| December 31, 2022 | 28.32M |
| September 30, 2022 | 29.96M |
| June 30, 2022 | 35.23M |
| March 31, 2022 | 42.04M |
| December 31, 2021 | 44.50M |
| September 30, 2021 | 46.53M |
| June 30, 2021 | 48.61M |
| Date | Value |
|---|---|
| March 31, 2021 | 4.368M |
| December 31, 2020 | 7.541M |
| September 30, 2020 | 9.121M |
| June 30, 2020 | 9.498M |
| March 31, 2020 | 10.69M |
| December 31, 2019 | -8.576M |
| September 30, 2019 | -8.375M |
| June 30, 2019 | -8.121M |
| March 31, 2019 | -7.776M |
| December 31, 2018 | -7.594M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.576M
Minimum
Dec 2019
48.61M
Maximum
Jun 2021
17.43M
Average
10.69M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
| FibroGen Inc | -228.12M |
| Cerus Corp | 49.37M |
| OPKO Health Inc | 1.253B |
| Stereotaxis Inc | 21.92M |
| SINTX Technologies Inc | 8.772M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.21M |
| Total Liabilities (Quarterly) | 17.96M |